ORCL
36
-5
AFL
42
5
V
38
6
PEG
34
2
EXPD
64
3
FDX
71
3
ALL
41
-3
CCI
44
3
CME
53
5
KR
38
4
HRL
33
15
PFG
67
3
IBM
68
3
GT
34
-2
SIG
57
2
C
65
-5
CI
50
-2
EW
51
-2
EXPE
80
-6
CNP
65
5
ORCL
36
-5
AFL
42
5
V
38
6
PEG
34
2
EXPD
64
3
FDX
71
3
ALL
41
-3
CCI
44
3
CME
53
5
KR
38
4
HRL
33
15
PFG
67
3
IBM
68
3
GT
34
-2
SIG
57
2
C
65
-5
CI
50
-2
EW
51
-2
EXPE
80
-6
CNP
65
5
Financhill
Back

Cue Biopharma, Inc. Stock Price Chart

Meet America's Newest $1B Unicorn

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
Sell
10

CUE
Cue Biopharma, Inc.

Last Price:
$0.28
Seasonality Move:
-6.19%

7 Day Trial

ALL ACCESS PASS

$ 7

Exxon and Chevron Have an Unlikely New Competitor

DISCLOSURE: EnergyX's Regulation A offering has been qualified by the SEC. Before investing, carefully review the offering circular, including the risk factors. The offering circular is available at
  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and CUE is experiencing slight buying pressure.

Cue Biopharma, Inc. Price Chart Indicators

Moving Averages Level Buy or Sell
8-day SMA: 0.37 Sell
20-day SMA: 0.35 Sell
50-day SMA: 0.51 Sell
200-day SMA: 0.69 Sell
8-day EMA: 0.35 Sell
20-day EMA: 0.38 Sell
50-day EMA: 0.47 Sell
200-day EMA: 0.42 Sell

Cue Biopharma, Inc. Technical Analysis Indicators

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.04 Sell
Relative Strength Index (14 RSI): 41.26 Sell
Chaikin Money Flow: -96443 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (0.29 - 0.47) Sell
Bollinger Bands (100): (0.47 - 0.81) Sell

Cue Biopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Technical Analysis for Cue Biopharma, Inc. Stock

Is Cue Biopharma, Inc. Stock a Buy?

  • Cue Biopharma, Inc. share price is 0.34 while CUE 8-day simple moving average is 0.37, which is a Sell signal.
  • The stock price of CUE is 0.34 while Cue Biopharma, Inc. 20-day SMA is 0.35, which makes it a Sell.
  • Cue Biopharma, Inc. 50-day simple moving average is 0.51 while CUE share price is 0.34, making it a Sell technically.
  • CUE stock price is 0.34 and Cue Biopharma, Inc. 200-day simple moving average is 0.69, creating a Sell signal.

CUE Technical Analysis vs Fundamental Analysis

Sell
10
Cue Biopharma, Inc. (CUE) is a Sell

Is Cue Biopharma, Inc. a Buy or a Sell?

Cue Biopharma, Inc. Stock Info

Market Cap:
26.8M
Price in USD:
0.34
Share Volume:
1M

Cue Biopharma, Inc. 52-Week Range

52-Week High:
1.54
52-Week Low:
0.23
Sell
10
Cue Biopharma, Inc. (CUE) is a Sell

Cue Biopharma, Inc. Share Price Forecast

Is Cue Biopharma, Inc. Stock a Buy?

  • Cue Biopharma, Inc. share price is 0.34 while CUE 8-day exponential moving average is 0.35, which is a Sell signal.
  • The stock price of CUE is 0.34 while Cue Biopharma, Inc. 20-day EMA is 0.38, which makes it a Sell.
  • Cue Biopharma, Inc. 50-day exponential moving average is 0.47 while CUE share price is 0.34, making it a Sell technically.
  • CUE stock price is 0.34 and Cue Biopharma, Inc. 200-day simple moving average is 0.42, creating a Sell signal.

Fundamental Analysis of Cue Biopharma, Inc.

Is Cue Biopharma, Inc. a good investment?

  • Analysts estimate an earnings decrease this quarter of $0.04 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.07 per share, and an increase next year of $0.06 per share.

Technical Analysis of Cue Biopharma, Inc.

Should I short Cue Biopharma, Inc. stock?

* Cue Biopharma, Inc. stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.